NDC 61314-624-94
CIMERLI .3 mg/.05mL
ranibizumab-eqrn · INJECTION, SOLUTION
CIMERLI is a injection, solution containing ranibizumab-eqrn at a strength of .3 mg/.05mL. Manufactured by Sandoz Inc.
Key Facts
- Brand Name
- CIMERLI
- Generic Name
- ranibizumab-eqrn
- NDC Code (Package)
61314-624-94- NDC Code (Product)
61314-624- Manufacturer
- Sandoz Inc
- Strength
- .3 mg/.05mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- BLA761165
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 12/12/2024
Recall History
No Recall HistoryView Full Drug Page
CIMERLI — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.